Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

Columnist Caroline Gainer has been sleeping a lot more than usual lately, so she investigates whether that's normal for ...

Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding ...

Some mental health doctors say they are seeing a big increase in the volume of mental health requests tied to current events ...

Looking back on the accomplishments of recent past presidents of CHEST, John A. Howington, MD, MBA, FCCP, hopes to “continue ...